PRF1 and neoplasm: Studies on tumors in these organs have shown that CD103+ T cells could release cytolytic granules containing perforin and granzyme B (GZMB) to directly kill tumor cells, which allows tumor antigens to be used for the activation of new tumor‐specific T cells.